Oleg Nodelman

Direktör/Styrelseledamot på ANAPTYSBIO, INC.

Förmögenhet: - $ per 2026-05-31

49 år

96 relationer

Health Technology

Finance

Miscellaneous

Profil

Oleg Nodelman is the founder of EcoR1 Capital, LLC, founded in 2012, where the title held is Portfolio Manager.
Current jobs include Chief Executive Officer at EcoR1 Panacea Holdings LLC; Independent Director at AnaptysBio, Inc. since 2021; Director at ReCode Therapeutics, Inc.; Director at Scorpion Therapeutics, Inc.; Director at Paratus Sciences Corp.; Non-Independent Non-Executive Director at Lakefront Biotherapeutics since 2024; Independent Director at Zymeworks, Inc. starting 2025; and Portfolio Manager at Ecor1 Capital LLC.
Former jobs include Chairman & Chief Executive Officer at Panacea Acquisition Corp.
II from 2020 to 2021; Chairman & Chief Executive Officer at Panacea Acquisition Corp.
from 2020 to 2021; Non-Executive Director at Addex Therapeutics Ltd. from 2012 to 2014; Independent Director at Nuvation Bio, Inc. from 2021 to 2023; Independent Director at Prothena Corp.
Plc from 2019 to 2024; Director at Aktis Oncology, Inc. from 2021 to 2026; Portfolio Manager at Biotechnology Value Fund LP from 2001 to 2012; and Portfolio Manager at BVF Partners LP.
Education includes an undergraduate degree from Georgetown University conferred in 1999.

Kända innehav i offentliga företag

Företag	Datum	Antal aktier	Värdering	Värderingsdatum
AKTIS ONCOLOGY, INC. -.--%	2026-01-12	0 ( -.--% )	- $	2026-05-31

Aktiva positioner av Oleg Nodelman

Företag	Position	Start
ANAPTYSBIO, INC.	Direktör/Styrelseledamot	2021-04-08
LAKEFRONT BIOTHERAPEUTICS NV	Direktör/Styrelseledamot	2024-10-07
ZYMEWORKS INC.	Direktör/Styrelseledamot	2025-02-17
Paratus Sciences Corp. Paratus Sciences Corp. BiotechnologyHealth Technology Operates as a biotechnology company	Direktör/Styrelseledamot	-
ReCode Therapeutics, Inc. ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics	Direktör/Styrelseledamot	-
Scorpion Therapeutics, Inc. Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision oncology therapies for cancer treatment	Direktör/Styrelseledamot	-
EcoR1 Panacea Holdings LLC	Verkställande Direktör	-
EcoR1 Capital, LLC EcoR1 Capital, LLC Investment ManagersFinance EcoR1 invests (long and short) in securities, consisting principally, but not solely, of equity and equity-related securities that are issued by biotechnology companies globally.	Verkställande Direktör	2012-01-01

Alla aktiva positioner av Oleg Nodelman

Tidigare kända positioner av Oleg Nodelman

Företag	Position	Slut
AKTIS ONCOLOGY, INC.	Direktör/Styrelseledamot	2026-05-20
░░░░░░░░ ░░░░░░░░░░░ ░░░	░░░░░░░░░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░ ░░░░	░░░░░░░░░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░	░░░░░░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░ ░░░░░	░░░░░░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░

Se detaljerna i Oleg Nodelmans erfarenhet

Oleg Nodelmans utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Oleg Nodelmans erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	17
Biotechnology Value Fund LP Biotechnology Value Fund LP Investment Trusts/Mutual FundsMiscellaneous Functions as a hedge fund	Miscellaneous
BVF Partners LP BVF Partners LP Investment ManagersFinance BVF generally pursues value-oriented investment strategies, investing primarily in the marketable securities issued by biotechnology companies. The focus of the BVF strategy is on fundamental, bottom-up analysis of individual issuers based on the theory that market mispricing exist because market prices do not incorporate all knowable economic and other relevant data.	Finance
Galapagos NV Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology	Health Technology
AnaptysBio, Inc. AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company	Health Technology
Georgetown University Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Addex Therapeutics Ltd. Addex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs	Health Technology
Prothena Corp. Plc Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies	Health Technology
EcoR1 Capital, LLC EcoR1 Capital, LLC Investment ManagersFinance EcoR1 invests (long and short) in securities, consisting principally, but not solely, of equity and equity-related securities that are issued by biotechnology companies globally.	Finance
ReCode Therapeutics, Inc. ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics	Health Technology
Scorpion Therapeutics, Inc. Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision oncology therapies for cancer treatment	Health Technology
Panacea Acquisition Corp. Panacea Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company	Finance
EcoR1 Panacea Holdings LLC
Nuvation Bio, Inc. Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates	Health Technology
Panacea Acquisition Corp. II Panacea Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company	Finance
Aktis Oncology, Inc. Aktis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers radiopharmaceuticals to treat tumor cancers	Health Technology
Paratus Sciences Corp. Paratus Sciences Corp. BiotechnologyHealth Technology Operates as a biotechnology company	Health Technology
Zymeworks, Inc. Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals	Health Technology